Open AccessWITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens
Author(s) -
Jamshid Vafaeimanesh,
Fahimeh Safarnezhad Tameshkel,
Hossein Ajdarkosh,
Azita Azarkeyvani,
Mahmoodreza Khoonsari,
Amirhossein Faraji,
Masoudreza Sohrabi,
Sima Aten,
Hossein Keyvani,
Farhad Zamani
Publication year - 2018
Publication title -
hepatitis monthly
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.264
H-Index - 37
eISSN - 1735-3408
pISSN - 1735-143X
DOI - 10.5812/hepatmon.66419
Subject(s) - daclatasvir , sofosbuvir , medicine , interferon , thalassemia , kowsar , hepatitis c , ribavirin , gastroenterology , pharmacology , virology , chronic hepatitis , virus